Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$191.17 - $325.63 $499 Million - $850 Million
2,610,975 New
2,610,975 $850 Million
Q4 2023

Feb 12, 2024

BUY
$160.99 - $215.69 $398 Million - $533 Million
2,470,419 New
2,470,419 $471 Million
Q3 2023

Nov 14, 2023

BUY
$194.33 - $283.97 $88 Million - $129 Million
453,048 Added 33.49%
1,805,771 $360 Million
Q2 2023

Aug 14, 2023

BUY
$223.05 - $302.68 $194 Million - $263 Million
868,871 Added 179.57%
1,352,723 $386 Million
Q1 2023

May 12, 2023

BUY
$175.41 - $217.92 $8.91 Million - $11.1 Million
50,821 Added 11.74%
483,852 $105 Million
Q4 2022

Feb 13, 2023

BUY
$204.38 - $296.82 $88.5 Million - $129 Million
433,031 New
433,031 $89 Million
Q1 2022

May 16, 2022

SELL
$127.96 - $207.36 $369,292 - $598,440
-2,886 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$165.13 - $241.83 $53,006 - $77,627
321 Added 12.51%
2,886 $515,000
Q3 2021

Nov 15, 2021

BUY
$163.99 - $235.57 $8,691 - $12,485
53 Added 2.11%
2,565 $528,000
Q2 2021

Aug 16, 2021

BUY
$131.45 - $201.49 $330,202 - $506,142
2,512 New
2,512 $477,000
Q4 2020

Feb 12, 2021

SELL
$67.44 - $103.72 $40.2 Million - $61.8 Million
-596,091 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$42.79 - $75.8 $32.3 Million - $57.1 Million
-753,710 Reduced 55.84%
596,091 $45.2 Million
Q2 2020

Aug 14, 2020

SELL
$27.25 - $47.53 $17.9 Million - $31.1 Million
-655,320 Reduced 32.68%
1,349,801 $63.9 Million
Q1 2020

May 14, 2020

BUY
$23.16 - $47.74 $16.9 Million - $34.7 Million
727,621 Added 56.96%
2,005,121 $66.5 Million
Q4 2019

Feb 11, 2020

BUY
$29.4 - $44.98 $37.6 Million - $57.5 Million
1,277,500 New
1,277,500 $56.1 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.